Back to Peptides
Weight Management
Tirzepatide
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Clinical research has demonstrated remarkable efficacy in weight management and glycemic control, surpassing many single-agonist compounds. Studies have explored its mechanisms of action including appetite suppression, delayed gastric emptying, and improved insulin sensitivity.
Weight ManagementDiabetes ResearchAppetiteMetabolic Health
Research Benefits
Superior weight loss outcomes in Phase 3 clinical trials
Dual receptor agonism for enhanced metabolic effects
Glycemic control improvements in diabetes research
Appetite and satiety regulation through multiple pathways
Axo's Research Digest
An AI-generated, plain-English overview of what the research explores for Tirzepatide — and how mature that evidence is.